Published 11:39 IST, August 9th 2020

US: Coronavirus cases approach 5 million mark as officials hope for vaccine by year-end

United States Coronavirus infection tally set new records, with more than 5 million cases United States is leading the chart of COVID 19 infections.

Reported by: Anmol Bali
Follow: Google News Icon
  • share
null | Image: self
Advertisement

On August 8, United States Coronavirus infection tally set new records, with cases approaching 5 million marks and United States is leing chart of COVID 19 infections. According to international media reports, with one out of every 66 residents infected and more than 160,000 deaths, nearly a quarter of world’s total deaths because of coronavirus, United States is worst affected because of pandemic. United States government is in hope to get an effective vaccine at year-end, which will stop spre of contagious virus.

Re: US: Doctors, Medical Students Organise Mass Campaign To Register Patients To Vote

Advertisement

This depressing milestone came as United States President Donald Trump signed executive orders, which plans to provide financial relief to American citizens affected by coronavirus pandemic after White House failed to reach a deal with Congress. On August 7 United States Labour department witnessed employment growth slump in month of July and need ditional aid from government. On August 5, while talking to media Dr.Anthony Fauci said re could be one effective vaccine at year-end and on or hand, United States President Donald Trump gave an optimistic view about vaccines saying that we would have a vaccine by vember when United States will undergo elections.

Re: Trump Signs Four Executive Orders For Ecomic Relief For Americans Amid COVID-19 Pandemic

Advertisement

Hope on vavax

American vaccine development company vavax said on August 4 that its experimental COVID-19 vaccine produced high levels of antibodies against vel coronavirus, according to initial data that came from a small and early-st clinical trial. It also said that it will start an important phase third trial as soon as in September, company also ded that it is able to produce 1 billion to 2 billion doses of vaccine incoming 2021. Talking to international media vavax research chief Gregory Glenn told that late-st clinical trial could potentially bring eugh data to obtain regulatory approvals as early as December.

(Im Credit- AP)

Advertisement

Re: vavax Claims Its Experimental COVID-19 Vaccine Produced High Levels Of Antibodies

Re: AP FACT CHECK: Trump’s False Push-On Preexisting Conditions

Advertisement

11:39 IST, August 9th 2020